| Dec 18, 2002 |
Spectrum Pharmaceuticals Completes Equity Offering |
|
|
| Dec 10, 2002 |
Spectrum Pharmaceuticals to Expand Study of Superficial Bladder Cancer Drug |
|
|
| Dec 8, 2002 |
NeoTherapeutics to Change Name to Spectrum Pharmaceuticals |
|
|
| Nov 21, 2002 |
NeoTherapeutics Completes Equity Offering |
|
|
| Nov 20, 2002 |
NeoTherapeutics Completes Issuance of Shares To Vendors |
|
|
| Nov 17, 2002 |
NeoTherapeutics Announces Resignation of Alvin J. Glasky, Ph.D. from the Company's Board of Directors |
|
|
| Oct 14, 2002 |
NASDAQ Approves NeoTherapeutics Listing on Small-Cap Market |
|
|
| Oct 6, 2002 |
NeoTherapeutics Updates Implementation of Strategy |
|
|
| Sep 30, 2002 |
NeoTherapeutics and GPC Biotech Sign Agreement To Co-Develop Phase 3 Oral Anti-Cancer Drug |
|
|
| Sep 29, 2002 |
NeoTherapeutics Provides Update on Nasdaq Listing Status |
|
|
| Sep 25, 2002 |
NeoTherapeutics Regains Compliance with NASDAQ Minimum Bid Requirement |
|
|
| Sep 4, 2002 |
NeoTherapeutics' Stockholders Approve Reverse Stock Split and Proposal for New Financings |
|
|
| Aug 21, 2002 |
NeoTherapeutics Announces Organizational Changes Designed to Bring On-Going Monthly Expenses Below $500,000 |
|
|
| Aug 20, 2002 |
NeoTherapeutics Announces New Financial Leadership |
|
|
| Aug 19, 2002 |
NeoTherapeutics Announces Major Strategic Restructuring |
|
|
| Aug 15, 2002 |
NeoTherapeutics Names Dr. Rajesh Shrotriya Chairman and Chief Executive Officer |
|
|
